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Abstract
Background: It is the aim of the World Health Organisation to eliminate soil-transmitted helminths (STH) as a
health problem in children. To this end, the goal is to increase anthelmintic treatment coverage for soil transmitted
helminths to reach 75 % in pre-school aged and school aged children by 2020 in endemic countries. In this paper,
we use mathematical models to investigate the impact of achieving this goal on the burdens of Ascaris lumbricoides,
Trichuris trichuria and hookworm.
Methods: We employ a deterministic fully age-structured model of STH transmission and mass drug administration to
examine the changes in worm burden in response to the known and projected coverage trends in children up to 2020
and beyond. Parameters are estimated from worm expulsion data and age intensity profiles before treatment using
maximum likelihood methods. Model validation is performed using reinfection studies for Ascaris and analyses are
conducted to assess the sensitivity of the predicted outcomes to variation in parameter estimates including transmission
intensity (R0), children’s contributions to the pool of infective stages and drug coverage levels.
Results: The impact of the required increase in coverage trends are quite different across the three species. Ascaris
burdens are reduced dramatically by 2020 with elimination predicted within studied the setting a further
10 years. For Trichuris and hookworm, however, impact is more limited, due to issues of drug efficacy (Trichuris) and
distribution of worms in the population (hookworm). Sensitivity analysis indicates that results are largely robust.
However, validation against Ascaris data indicates that assumptions concerning re-infection among children may have
to be revised.
Conclusions: The 2020 coverage target is predicted to have a major impact on Ascaris levels by 2020. However, there
is evidence from model validation that Ascaris in children is more resilient to treatment than currently assumed in the
model. Broader coverage across all age classes is required to break transmission for hookworm and alternative dual
drug treatment approaches are needed for Trichuris.
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Background
The World Health Organization’s (WHO) policy for con-
trol of the soil transmitted helminths (STH) largely cen-
tres on two groups, preschool aged children (pre-SAC),
and school-aged children (SAC). The strategy for treat-
ment is based on the argument that pre-SAC and SAC
often harbour heavy infection which will have a detrimen-
tal impact on anaemia, child growth, and development.
Although this largely holds for Ascaris lumbricoides and
Trichuris trichuria, where the intensity of infection is
highest in these age groupings, it holds less well for the
hookworm species since infection is often greatest in
adults [1]. The current WHO guidelines focus on SAC,
both for monitoring infection and as a target for treat-
ment, although treatment of pre-SAC and women of
childbearing age is also recommended where sustainable
delivery mechanisms exist, especially in areas of intense
transmission [2, 3]. The guidelines recommend treating
SAC annually where any STH prevalence falls between
20 % and 50 % and twice a year where it exceeds 50 % [2].
WHO aims to scale up mass drug administration
(MDA) for STH, so that by 2020, 75 % of the pre-SAC
and SAC in need will be treated regularly [3–6]. Progress
has been good in some areas, but less so in others
(Fig. 1). Pharmaceutical companies who manufacture the
main anthelmintics have continued to increase drug do-
nations. Slow progress in raising coverage in some coun-
tries is due in part to the logistical challenges in getting
donated drugs to rural populations, who are often be-
yond “the end of the road.” At present, many countries
with endemic STH infections are not availing themselves
of the freely donated drugs to treat children.
The current situation with coverage as reported by
WHO is summarised in the third progress report of the
London Declaration [5]. In 2013, global coverage of those
in need was 39 % for SAC and 49 % for pre-SAC [6]. In
2015, STH moved from yellow to green in the progress
score card chart (recently developed by Uniting to Com-
bat NTDs), in part due to better coordination between
UNICEF and WHO which has led to an improvement in
reporting of coverage for pre-SAC. The coverage in this
age grouping now exceeds 50 %. Coverage in SAC is
reported as 39 %, which, it is argued in the report, is on
track for a 75 % target in 2020.
We present the results of our analysis of the predicted
impact of achieving 75 % MDA coverage in pre-SAC
and SAC by 2020 on the intensity of infection as a func-
tion of host age. The study was conducted under the
umbrella of the Neglected Tropical Disease Modelling
Consortium, which is supported by the Bill and Melinda
Gates Foundation [7]. To reflect different settings, where
one or other of the three major STH species may be the
dominant infection, analyses are performed separately for
Ascaris, Trichuris and the hookworms. The calculations
are based on deterministic mathematical models of the
transmission dynamics of the parasites under MDA with
key parameter estimates derived from field worm expul-
sion epidemiological studies [8, 9]. The analysis is based
on the premise that the WHO MDA coverage targets are
reached by 2020. We also assess the time taken once
reached for the transmission dynamics to settle to its new
steady state, whether this be the persistence of infection at
a lower level than prior to scaling up MDA or elimination,
if the breakpoint in transmission is breached in, for
example, low or medium transmission settings.
Methods
A deterministic fully age-structured mathematical model
of the transmission dynamics of helminths with a direct
lifecycle is used to examine the impact of MDA on the
pre-SAC, SAC and adult age groupings. The structure of
this model has been described in a series of recent publi-
cations [10, 11] and in the Additional file 1 to this paper.
It is based on a model framework first described by An-
derson & May [12]. The model describes the evolution
of the mean worm burden in a host as a continuous
function of age, although results are generally presented
as averages across the pre-SAC, SAC and adult age
groups. Hosts contribute infectious material to a single
reservoir and are re-infected from it. The model is based
on a negative binomial distribution for worms in a host
and hence the probability of a host of a given age having
a given worm burden can be directly calculated from the
output. Stochastic individual based simulations have also
been performed but are not reported in this paper since
the mean intensity of a large number of runs is close to
Fig. 1 Average national percentage coverage of Pre-SAC (blue line)
and SAC (orange line) with STH drug treatment in areas of endemic
infection as reported by WHO [13] (solid lines). Linear extrapolation is
used for the interval 2013 – 2020, after which coverage is assumed to
remain at 75 % (broken lines). Drug efficacy is as defined in Table 1
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the deterministic results. Stochastic simulations permit
the examination of the impact of predisposition to infec-
tion and variation in adherence to treatment at each
round of treatment but these results will be reported in
a separate paper.
Treatment coverage in the pre-SAC and SAC age
groupings (2–4 years of age and 5–14 years of age re-
spectively) was represented by the national percentage
coverage of pre-SAC and SAC with STH drug treatment
in areas of endemic infection as reported by WHO [13],
shown in Fig. 1. A figure of 75 % was assumed for both
age groupings in 2020 and beyond and coverage for the
years 2013 to 2020 was determined by linear interpolation.
These values represent national means and coverage in in-
dividual locations will vary considerably from these values.
However, given sufficient linearity in the response of the
model to variation in coverage, results should be indicative
of large-scale national trends in worm burden. The drug
efficacies for albendazole for the three species were those
reported by Vercruysse et al. [14] and listed in Table 1.
Parameter assignments for the major population and
transmission processes were as defined in Table 1 based
on epidemiological studies of the three major STH spe-
cies, involving cross-sectional worm expulsion studies
across the full population age range. Parameters were fit-
ted to age-expulsion worm count paired data for the
three major STH species using maximum likelihood
techniques. Additional information was obtained from
paired worm burden/egg output data, where possible
from the same study. The methods used are discussed in
the SI. The worm expulsion profiles chosen for the three
STH species were as follows: Ascaris lumbricoides in
India – Elkins et al. [15]; Trichuris trichuria in St Lucia
– Bundy et al. [16]; hookworm (Necator americanus) in
Zimbawe – Bradley et al. [17] (Fig. 2). Where possible,
we have estimated parameters using the full age struc-
tured model and all relevant data. As a result, parameter
values may differ from those quoted in the original stud-
ies, where parameters are usually estimated separately.
Treatment coverage is assumed to be at random at
each round of MDA in each age grouping. This is un-
likely to be true in reality and a future publication will
examine compliance issues within a stochastic frame-
work. If those not treated are predisposed to this state
for social or behavioural factors, the impact of MDA at
75 % coverage will be less than predicted in the results
discussed in this paper.
Host demographic details (age dependent death rates
and population pyramids) were taken from data published
by the DHS program with the profile in Kenya in 2003
chosen to represent a typical profile [18].
Model validation
Validation of model predictions is essential and can be
performed in a variety of ways. Qualitative comparisons
of model prediction with observed pattern of reinfection
post mass treatment is one approach. Ideally, however,
quantitative comparisons of predicted outcome of the
impact of MDA require parameter estimation using data
from a defined population with little or no past treatment
and then the comparison of expected and observed pat-
terns of reinfection after intervening rounds of chemo-
therapy. Precise information on who has been treated and
how often is very valuable in performing such compari-
sons, but rare in practice. In comparing model predic-
tions with observations, the quality of agreement can
only be judged in the light of the uncertainties associ-
ated with the model. The current model describes the
evolution of the negative binomial distributions that de-
scribe worm burdens at a given age and so readily lends
itself to the construction of credible intervals for the
observed data. Beyond this, however, there are known
biases in common diagnostic techniques, with false
negative results leading to underestimates in intensity
Table 1 Parameter values estimated using maximum likelihood methods and used in the numerical evaluations of model
predictions for each parasite
Parameter Ascaris Trichuris Hookworm Source
Basic Reproductive number, R0 2.12 1.72 2.34 Fitted
Adult worm life expectancy 1 year 1 year 2 years [12]
Negative binomial clumping parameter, k 0.90 0.38 0.35 Fitted
Density dependence fecundity parameter, ɣ 0.07 0.0035 0.08 Fitted
Age-specific transmission parameter, βi for age group i’s contact with infectious





0.03, 0.09, 1, 2.5 Fitted
Drug efficacy as a proportion of worms killed by Albendazole 0.99 0.50 0.95 [14]
Source of age - mean intensity profile for fitting Elkins et al.
South India [15]





The age intensity profiles from the cited sources based on worm expulsion were used to derive estimate of R0, βi and k. The values of ɣ were derived from egg
per gram of faeces and worm expulsion counts [transmission age groups: Ascaris and hookworm: 0–2;2–5;5–15;15+; Trichuris: 0–2;2–7;7–12;12+]
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and prevalence measures. These effects are as yet
poorly characterised and not included in our model.
New tools, such as quantitative PCR, offer some hope
for the future in providing precise scores for prevalence
and perhaps even egg burdens in stools. A further com-
plication arises from density dependence in egg produc-
tion by female worms which can result in higher per
capita egg output post the initial round of treatment
during the early phases of reinfection as recorded by
Elkins et al. [19].
Model validation has rarely been attempted for hel-
minth infections, but it is a central need for ongoing and
future epidemiological studies of MDA impact, if predic-
tions on coverage requirements to interrupt transmission
are to carry weight amongst public health policy makers.
We report a validation exercise using a reinfection study
of Ascaris recording prevalence, epg, epd (eggs per female
worm per day) and worm expulsion in a community in
southern India that had not previously been treated prior
to the initiation of mass drug administration [15, 19]. We
also examine the sensitivity of model predictions on the
impact of achieving 75 % coverage in pre-SAC and SAC
to the value of basic reproductive number (R0) which re-
cords the transmission intensity in a defined location.
Results
We present the results of the numerical evaluations of
model behaviour in the form of a set of graphs for each of
the three main STH species in settings where MCMC
methods were employed to estimate R0 and the egg pro-
duction and contact parameters for three age groupings,
pre-SAC, SAC and Adults (Fig. 3). The transmission par-
ameter, R0, defines the average number of off spring pro-
duced by one female worm that transmit and survive to
reach reproductive maturity in the human host (7). The
values chosen for the three parasites are as listed in Table 1.
The first set of graphs are histograms recording the
initial mean endemic female worm burden in pre-SAC,
SAC and Adults (15+ years old) and the respective
worm burdens at 2020 with the prescribed treatment
coverage levels in 2020 with a time series of coverage as
noted in the Methods section and Fig. 1. The results for
the three species of STH are recorded in Fig. 3 for
Ascaris, Trichuris and hookworm.
The impact of achieving the goals of 75 % coverage of
Pre-SAC and SAC was different for the different STH spe-
cies and for various age groupings. The predicted impact
for Ascaris is much greater than that for hookworm and
Trichuris. The impact on Trichuris was similar to Ascaris,
but lower due to the lower drug efficacy (see Table 1). It
should be noted that with the assumed age profile (derived
from a set of field studies in St Lucia [20]) from which
parameters were estimated there was a low pre-control
worm burden in the adults (who are untreated). In set-
tings where adults have a higher pre-control burden the
impact would be even less.
The impact on hookworm was lower for all three age
groups, compared to Ascaris and Trichuris. The overall
worm burden was only reduced by 22 % because the bur-
den of hookworm infection lies largely in untreated adults
due to the rising burden of infection with age (Fig. 2) This
effect is also observed in other models of PCT for hook-
worm [21]. Consequently, child-targeted treatment does
not significantly impact the overall level of transmission in
the community. Children are therefore likely to become
reinfected quickly after treatment from the adult reser-
voirs of infection [22].
Further assessment of model predictions is provided in
Fig. 4 which plots changes in mean female worm burden
Fig. 2 Maximum likelihood estimator fits to worm expulsion data for Ascaris (Panel a data from Elkins et al.), Trichuris (Panel b data from Bundy et
al.), and Hookworm (Panel c data from Bradley et al. – Necator americanus). The fits are performed for individual worm counts for Ascaris and
Trichuris, and for mean counts for hookworm (in the absence of individual-level data)., The solid line is the mean individual worm burden as a
function of age for the maximum likelihood parameter estimates and the dotted line is the 97.5 percentile for individual worm burden from the
model, based on the assumed negative binomial distribution. The crosses are the raw data
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for the three STH species form the start of treatment to
2020 where 75 % coverage of both Pre-SAC and SAC is
achieved and for a further 10 years at the 2020 levels.
The plots record predicted changes in worm burdens in
Pre-SAC, SAC and Adults. The overall population mean
is also plotted as a solid black line. The projections show
that although projected coverage levels stabilise after
2020, the full impact on worm burden is generally not
achieved until some years later. For Ascaris, the final
coverage level is just sufficient to eliminate the parasite in
the studied setting, but that is not achieved for a further
5–6 years. Likewise, Trichuris does not reach its new equi-
librium for a similar length of time. Hookworm stabilises
much more rapidly, since treatment has had a relatively
small effect on the overall worm burden in the population.
Note that the total benefit of achieving the current
coverage goals is dependent on the rate that treatment
coverage is scaled up from 2015 until 2020. The faster the
rate of scale up, the greater the total impact of MDA.
Figure 5 shows the equivalent trend in the percentage of
individuals with worm burdens above a threshold associ-
ated with morbidity and developmental deficits [23]. The
thresholds are defined for each of the STH species
and are categorised into 3 age categories: [0–4 years],
[5–9 years], [10+ years]. These thresholds have been used
to define morbidity and disease burden and the impact of
treatment in a range of studies [24–27]. The effect of in-
creasing coverage on high worm burden is broadly the
same as the effect on mean worm burden (Fig. 3), but
changes in mean worm burden having a smaller impact
on high burden percentage when mean worm burden is
high and a larger impact when mean worm burdens are
low. As a result, the impact on high worm burden in SAC
and pre-SAC is very strong for hookworm, but this hides
Fig. 3 Predicted Ascaris (panel a), Trichuris (panel b) and hookworm (panel c) burdens in Pre-SAC, SAC, Adults and the overall population mean
prior to treatment and in 2020 with 75 % treatment coverage of Pre-SAC and SAC. No adult coverage is assumed. Percentages indicate the
respective worm burden reduction. Parameter values are as defined in Table 1
Fig. 4 Changes over time from 2000 to 2030 in a medium transmission setting (R0 values are around 2.0 – see Table 1) of the average female
Ascaris (panel a), Trichuris (panel b), and hookworm (panel c) burdens in Pre-SAC, SAC and adults. Treatment trend as described in Fig. 1. The
overall population-average worm burden is plotted as a solid black line
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the fact that relatively high mean worm burdens still exist
in adults and hence in the population as a whole. As with
all indirect measures of disease burden, the high bur-
den thresholds are subject to considerable uncertainty.
The effect of this is addressed in the Additional file 1.
Sensitivity analyses
The predictions presented in Figs. 3, 4 and 5 are based
on MLE parameter estimates derived from particular
baseline datasets, parameters taken from the literature
and predictions of future trends in coverage that will
meet WHO goals. However, different baseline datasets
will yield different parameter values and the estimation
process itself introduces uncertainty in parameter values.
Equally, the 75 % target coverage will vary on a local
level, with some communities achieving higher rates and
others falling short. In Table 2, we examine the impact
of such uncertainties in key parameters on the percent-
age drop in the predicted outcomes by 2020. The table
records the variation in predicted outcomes for changes
in key parameter values above and below the value esti-
mated from data. The parameters examined are the basic
reproductive number (R0 = +1.0, −0.5), MDA coverage at
2020 (60 % or 90 %) and the age-specific transmission
Fig. 5 Evolution of the percentage individuals with worm burdens above morbidity thresholds (see main text) for Ascaris (panel a), Trichuris
(panel b), and hookworm (panel c) in Pre-SAC, SAC, adults and also over the whole population, with treatment trend as shown in Fig 1.
Parameterization as for simulations in Fig. 4
Table 2 Sensitivity analyses of model projections to changes in the values of key parameters
Pre-SAC SAC Adults Overall population
Ascaris
Fitted parameters (see Table 1) 71 75 63 70
Higher and lower transmission setting (R0 + 1.0, −0.5) 35, 99 45, 99 24, 99 36, 99
Coverage level achieved in 2020 (60 %, 90 %) 59, 82 64, 85 51, 73 58,80
The degree of exposure and contribution of Pre-SAC and SAC to the
infectious reservoir (β2 and β3 + 50 %, −50 %)
83, 48 85, 56 76, 37 82, 45
Trichuris
Fitted parameters (see Table 1) 43 48 40 44
Higher and lower transmission setting (R0 + 1.0, −0.5) 24, 80 31, 81 20, 77 24, 79
Coverage level achieved in 2020 (60 %, 90 %) 37, 49 42, 54 34, 45 38, 49
The degree of exposure and contribution of Pre-SAC and SAC to the
infectious reservoir (β2 and β3 + 50 %, −50 %)
45, 38 50, 43 43, 32 46, 37
Hookworm
Fitted parameters (see Table 1) 39 50 16 22
Higher and lower transmission setting (R0 + 1.0, −0.5) 36, 43 48, 54 12, 21 19, 27
Coverage level achieved in 2020 (60 %, 90 %) 34, 43 45, 55 14, 17 20, 24
The degree of exposure and contribution of Pre-SAC and SAC to the
infectious reservoir (β2 and β3 + 50 %, −50 %)
45, 33 55, 45 24, 6 32, 10
The numerical values record the percentage reduction in the predicted mean intensity of infection in each age group from a rising treatment coverage to 75 % in
2020 as compared to baseline in 2003. The default parameters are in Table 1
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parameter βi for the Pre-SAC and SAC age groups (+ or –
50 %, to reflect the importance of children in contributing
to the pool of infective stages for the whole population).
As already observed, the impact of assumed coverage
trends on Ascaris is sufficient to eventually bring about
elimination in the studied setting, while for Trichuris and
hookworm, species-specific factors limit its effect (low
drug efficacy for the former and most worms being in
adults for the latter). The degree of impact is reflected in
the sensitivity, with Ascaris generally highly sensitive to
changes and the other two species much less so. This fur-
ther highlights the need to consider alternative strategies
for MDA for Trichuris and hookworm: the fact that quan-
titative change has little effect on outcome points to the
need new approaches to control. Other control measures
such as latrines in schools, the wearing of shoes (in areas
where hookworm is the dominant STH) and improved hy-
giene in general, can, in combination with MDA, may be
necessary to achieve long-term goals. Looking in more de-
tail, it’s clear that Ascaris and Trichuris are much more
sensitive to transmission intensity variations than hook-
worm. This is a consequence of the dominant role of chil-
dren in the reinfection cycle in the former species as
opposed to hookworm, where adults drive reinfection.
Perhaps most surprising is the relative lack of sensitivity
of the outcome to changes in the exposure of children to
infectious material. The variation examined represents a
factor of 3 between highest and lowest value, but the out-
come only varies by about 10–15 %. The relative values of
the exposure parameter are determined by the details of
the baseline age profile shape, which can vary significantly
between studies (e.g. for hookworm [1]). It is reassuring
from the modelling point of view that results of interest
are not overly sensitive to potentially variable aspects of
the underlying data.
Interrupting transmission
Breaking transmission is not yet the aim of current
WHO policy, which is currently targeted at reducing
morbidity in children. However, there is growing interest
in investigating the feasibility of interrupting transmis-
sion of STH by crossing an unstable breakpoint in the
parasite’s transmission dynamics created by the dioe-
cious nature of sexual reproduction which requires the
presence of female and male worms in the same host to
produce viable offspring [28–30].
Previous work has shown that achieving the current
coverage goal could lead to the elimination Ascaris in
certain transmission settings with low R0 values (around 2)
as detailed in a series of recent publications [10, 11, 31], al-
though this outcome is particularly sensitive to the value of
the fecundity parameter, γ. The current Ascaris par-
ameter regime falls within this range, as can be seen
from Fig. 4. For higher R0 values (R0 = >2.5), trans-
mission settings, models predict that elimination can
only be achieved by extending treatment to adults to
some degree or by increasing the frequency of treatment
to twice a year [11].
The current target of 75 % coverage of Pre-SAC and
SAC was not projected to be sufficient for the elimin-
ation of Trichuris and hookworm (as indicated in Fig 4).
This is because the majority of hookworms are har-
boured by adults, and for Trichuris the treatment effi-
cacy of albendazole and mebendazole monotherapy is
low [14, 22, 32]. Consequently, the elimination of hook-
worm requires the treatment of adults, and the elimin-
ation of Trichuris requires the use of a two drug
treatment combination that has a higher drug efficacy
(such as ivermectin co-administration with albendazole or
mebendazole) [H C Turner et al.,‘An economic evaluation
of expanding hookworm control strategies to target the
whole community’, submitted; H C Turner et al., ‘Analysis
of the population-level impact of co-administering iver-
mectin with albendazole or mebendazole for the control
and elimination of Trichuris trichiura’, submitted].
Table 3 records the minimum number of annual
rounds of treatment required for Ascaris to be elimi-
nated (under the current parameters) as a function of
proportional treatment coverage in Pre-SAC and SAC.
In this case, the trend in coverage is not included and it
is assumed that treatment is maintained at the given
coverage level throughout. It is important to note that
these are deterministic projections. Stochastic simula-
tions show that to achieve success with a high degree of
certainty, longer durations of high coverage are required.
Table 3 indicates that elimination is still possible at a
range of coverage levels less demanding than 75 %, albeit
at a greater number of years of treatment. The number
of rounds quoted in Table 3 is from the untreated base-
line. Given the impact of the trend up to 2020, the num-
ber of additional years will be less than those quoted in
the table. The symmetry of Table 3 shows that the contri-
bution of SAC and Pre-SAC groups towards elimination is
approximately equal under the current parameter regime.
While the Pre-SAC age group is less accessible to treat-
ment than SAC, it also represents a smaller fraction of the
population. These factors may prove important as WHO
goals switch from control to elimination in future.
Model validation – Ascaris
As outlined in the Methods section, validation of model
predictions requires comparison of predictions post
treatment with observed outcome based on information
on parameter estimates and initial conditions and data
on who is treated and how frequently and who is sur-
veyed. Given the nature of the models, the gold standard
data is individual and longitudinal with expulsion data at
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the initial and final surveys and a history of treatment.
Few published epidemiological studies on STH match
this level of rigour. One such study that meets the cri-
teria of worm counts at two time points, plus informa-
tion on demography for the village treated and details of
MDA coverage, is that by Elkins et al. [15, 19]. We are
in the fortunate position of having access to the raw data
for each individual treated for this study, despite the fact
that is was carried out in 1983–84. This raises an issue
concerning STH epidemiological studies. Far too few
record data electronically and make such data freely
available electronically. This is an important need in the
coming years as MDA coverage is hopefully increased.
The arm of the study providing the current data com-
prises a cross sectional survey using expulsion tech-
niques covering 68 % of the population in January 1984,
followed by a re-infection survey in December of the
same year, also providing worm burden data.
The results of the validation analysis on the Elkins et
al. data is displayed in Fig. 6. Panel a records the fit of
model predictions and their 95 % credible intervals, to
the observed mean worm counts for each age group
after 11 months of reinfection. Graph b records the ori-
ginal model fits to the baseline data from which parameter
estimates were initially derived to make the reinfection pre-
dictions using maximum likelihood. Note that no revised
parameter estimates were made using the reinfection
data – so this is ‘true’ validation, in the sense of using the
predefined model to make predictions of MDA impact.
Note the fit is good overall, but less good for the 5–10 year
old age group. The reasons for this mismatch are unclear
at present. A variety of factors could be important, such as
much higher recycling of infection within this age group
(they perhaps largely infect themselves), or changes in
worm aggregation between age classes. We assumed an
overall k value for the negative binomial distribution of
worms per person in the total population. We know that k
varies with age [33, 34], and this could influence the qual-
ity of the fit. Both issues will be explored in future work.
Discussion
We summarise the main conclusions of our analyses
by STH species, before turning to more general
considerations.
The stated aim of WHO to achieve 75 % coverage by
2020 for children will have a very considerable impact
on Ascaris. In areas of low and medium transmission
(R0 < 2.5) such coverage will eventually result in trans-
mission interruption given it is sustained or treatment
frequency is altered to biannually. In areas of high trans-
mission with limited past experience of treatment, high
coverage levels are required or coverage should be
extended to include adults.
For Trichuris, the situation is less encouraging given
the poor efficacy of albendazole and mebendazole for
this parasite. As discussed elsewhere [H C Turner et al.,
‘Analysis of the population-level impact of co-administering
ivermectin with albendazole or mebendazole for the control
and elimination of Trichuris trichiura’, submitted], dual
drug therapy involving ivermectin co-administration with
albendazole or mebendazole is required to achieve very low
burdens by 2020. Current treatment guidelines will not
achieve a great deal and hence a revision is required for
areas where Trichuris is the dominant STH.
A similar picture emerges for hookworm, but for differ-
ent reasons. As discussed in previous publications [22],
Table 3 The number of rounds of annual treatment (hence years) in Pre-SAC and SAC required to eliminate transmission for Ascaris
as a function of coverage in Pre-SAC and SAC (parameter values as defined in Table 1)
Coverage of SAC
0 10 % 20 % 30 % 40 % 50 % 60 % 70 % 80 % 90 % 100 %
Coverage of Pre-SAC 0 NA NA NA NA NA NA NA NA NA NA NA
10 % NA NA NA NA NA NA NA NA NA NA 23
20 % NA NA NA NA NA NA NA NA NA 21 16
30 % NA NA NA NA NA NA NA NA 20 15 12
40 % NA NA NA NA NA NA NA 20 15 12 10
50 % NA NA NA NA NA NA 21 15 12 10 8
60 % NA NA NA NA NA 22 15 12 10 8 7
70 % NA NA NA NA 24 16 12 10 8 7 6
80 % NA NA NA NA 17 12 10 8 7 6 6
90 % NA NA NA 18 13 10 8 7 6 6 5
100 % NA NA 21 14 11 9 7 6 6 5 5
NA denotes that it is not possible to achieve elimination within 25 years with the defined level of coverage in Pre-SAC and SAC
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most worms are harboured by adults and hence treatment
coverage must be broaden to encompass this age group.
In all three cases some ‘herd’ impact on transmission
can be observed in adults as a consequence of treating
Pre-SAC and SAC (Figs. 3 and 4). Such effects have been
observed in practice in, for example, areas of high Tri-
churis transmission [20]. In all cases, however, the speed
of gearing up coverage to 75 % will be crucial. Trying to
achieve this level before 2020 is highly desirable. The
overall impact for all could also be improved by extend-
ing current guidelines to encompass adults wherever
possible, perhaps by using the school as a focus for treat-
ment [H C Turner et al., ‘An economic evaluation of
expanding hookworm control strategies to target the
whole community’, submitted].
The coverage trend shown in Fig. 1 which drives the
evolving parasite burdens represents an average coverage
across many countries. In reality, this will hide considerable
geographical variation. Our sensitivity analysis looked at
the response to the coverage level achieved in 2020, which
partially addresses this question. The indication is that, for
Ascaris, large variations in coverage across countries will
result will result in areas of elimination interspersed among
areas in which the parasite is still endemic. For Trichuris
and hookworm, the resultant variation is likely to be much
less. On a national scale, the linearity in the response of the
models to variation in coverage (See Table 2) indi-
cates that average impact will be well represented by
average coverage.
Looking at the percentage of high burden individuals
in the population, the trend under increasing coverage
broadly matches that seen for the mean worm burden in
different age categories and overall, with the distinction
that the impact on the prevalence of high burden individ-
uals is much greater when mean burden is low. Perhaps
more important is the sensitivity of high burden prevalence
Fig. 6 Validation of model behaviour. Panel a records the mean worm burden and 95 % credible intervals for the predicted mean intensity of
infection by age class (1 = 0–5 years; 2 = 5–10 years; 3 = 10–20 years; 4 = 20–30 years; 5 = 30-45years and 6 = 45–70 years), plotted against the
observed mean values recoded in the raw data from the Elkins et al. study of Ascaris reinfection [19]. Graph b records the original baseline data
as mean intensity of infection by age group and the model fit carried out to estimate the key parameters (k, γ, βi, and R0). T
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to the threshold values that define it, as discussed in the
Additional file 1. The range of uncertainty in these values
carries across into large changes in the absolute values of
high-burden prevalence in age groups and in the ratios be-
tween them.
The WHO guidelines state that one of the goals of pre-
ventive chemotherapy (PCT) is the reduction of heavy
burden in children (SAC and pre-SAC) to less than 1 %,
as defined by moderate to heavy egg output [35, 36].
While egg count-based metrics are easier to apply to col-
lected data, as a proxy for high worm burden, they have
important drawbacks. The connection between worm bur-
den and prevalence of moderate to high egg count can
only be made with the knowledge of the net egg output
per worm and variability in egg output for a given worm
population. These parameter values are either largely un-
known (variability) or exhibit a large range across different
studies (egg output per worm [37]). In addition, evi-
dence suggests that the distribution of egg output per
worm has a high variance and skew [38, 39], resulting
in potentially inaccurate and biased assessments of
the underlying worm burden. As such, this suggests
that moderate to high egg counts are a poor quality
indicator of underlying worm distribution.
More generally, we have explored sensitivities to vari-
ation in key parameter estimates but in qualitative terms
the above conclusions hold. Other factors, however,
could influence the validity of these predictions.
The first concerns acquired immunity dependent on
past exposure to infection. At present the evidence
for this as a key factor in the acquisition of infection
is limited, despite the many host responses to parasite
antigens. If a degree of acquired immunity was important
in limiting the acquisition of infection, especially in adults,
then our conclusions will be too pessimistic in the short
term (post treatment reinfection restricted by past expos-
ure) but too optimistic in the longer term once repeated
treatment has acted to reduce the build-up of immunity
in children and adults.
The second is the use of a deterministic mathemat-
ical model framework. Our reasons for doing so relate
to the fairly predictable population dynamics of STH,
where post perturbation the population bounces back
to a pre-perturbation level in a monotonic manner.
Our preliminary analyses of individual based stochas-
tic models show that mean trajectories are in broad
agreement with the deterministic results. Where they dif-
fer concerns the fact that a stochastic framework permits
the generation of a frequency distribution of extinction
times for a given set of parameter values with treatment
coverage sufficient to break transmission. As such the
certainty of the deterministic predictions is false –
there will only be a certain probability of going ex-
tinct at the times documented in Table 3.
Our stochastic framework is also an individual-based
approach and as such permits the exploration of more
causes of heterogeneity, such as pre-disposition to heavy
or light infection. Most importantly, they do permit ex-
ploring the consequences of relaxing our assumption of
a random choice of individuals to treat at each round of
treatment. It seems likely from studies of MDA for other
helminths such as onchocerciasis and lymphatic filariasis
[40, 41], that those not treated may be predisposed to
this state of non-compliance by behavioural or social
factors. This topic will be the subject of a future
publication.
Mathematical models play an important role in infec-
tious disease epidemiology, not just in prediction, but
also in helping define what needs to be measured to facili-
tate a better understanding of observed pattern. One
factor that emerges from our present analyses is the defin-
ition of what constitutes low, medium and high transmis-
sion settings. WHO defines these in terms of prevalence
bands from epg measures for each species (and for schis-
tosomes) [42]). Given the high variability of these counts
due to poor diagnostic capabilities, epg measurements are
poor, inaccurate indicators of transmission intensity.
However, the value of faecal samples as a source for
the accurate measurement of infection intensity may
change in the future as new quantitative PCR methods be-
come available.
The model validation analyses described in the results
section is the first such attempt for models of helminth
infection transmission dynamics (and response to con-
trol interventions). The results are encouraging and give
confidence for the use of the model to provide the tem-
plate for policy formulation for MDA control of STH.
There is one discrepancy, however, concerning the predic-
tion of reinfection in 5–10 year olds, where a much faster
reinfection rate occurs than predicted. One implication of
this feature is that Ascaris in children is probably more re-
silient to treatment than suggested by our current model
results. This will be explored in a future publication, with
model modifications to include age dependency in the
negative binomial aggregation parameter, k, and a ‘who in-
fects whom’ matrix that gives greater importance to chil-
dren largely infecting each other. Studies based on whole
parasite genome sequencing could help provide independ-
ent data on who infects whom in future molecular
epidemiological studies. Excepting the anomaly for re-
infection of children, the re-infection distribution is a rea-
sonable fit. One conclusion from this is that the region
studied was largely epidemiologically self-contained: no
force of infection outside that generated by the parasites
within the model was required achieve the observed
bounce-back. Given that the original study was carried
out in rural India in the early 80s, perhaps the epidemio-
logical isolation is not surprising. With increasing human
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mobility, the movement of infectious worms and infec-
tious material over long distances may become important,
particularly for the re-introduction of parasites into a re-
gion where elimination has been achieved. More relevant
to the understanding of current endemic patterns of infec-
tion are the regular movements within communities, e.g.
children moving between school and village. Studies are
currently under way which will collect data on these
aspects of spatial heterogeneity.
Conclusion
We return to the aims of this study; namely, to evaluate
the potential impact of current WHO health policy aims
for STH. Formerly, these assessments have been made
on the basis of experience and expert opinion. However,
with the increasing availability of relevant data and the
mathematical tools to use it to inform models of parasite
dynamics and response to treatment, this process should
be put on a more scientific footing. When the World
Health Assembly announces broad goals for the future
control of NTDs, it is highly desirable that these aims
are accompanied by calculations on what is precisely
needed to achieve them, year by year of the time frame
defined for the achievement of the stated goals. We hope
the current analyses reported in this paper highlight the
value of doing so.
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